Two anti-inflammatory drugs, abatacept and infliximab, reduced deaths among patients hospitalized with severe COVID-19, according to a national study led by Washington University School of Medicine in St. Louis. William G. Powderly, MD, (right) who led the large clinical trial, discusses patient conditions with Maanasi Samant, MD, in the intensive care unit at Barnes-Jewish Hospital, one of the major trial sites, during the COVID-19 pandemic.
Better diet can help prevent the development of dementia as people age
“Insights & Implications in Gerontology: The Vital Role of Nutrition in Brain Health,” a new publication from the Gerontological Society of America, explores nutritional choices
April 4, 2024